Is this you? Create Your Porfile
Avatar

Annarita Ianniello

Seconda Università degli Studi di Napoli

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Annarita Ianniello is active.

Explore More

Publication

Featured researches published by Annarita Ianniello.

L'Endocrinologo | 2016

Terapia radiorecettoriale dei tumori neuroendocrini pancreatici

Silvia Nicolini; Maddalena Sansovini; Stefano Severi; Manuela Monti; Annarita Ianniello; Federica Matteucci; Giovanni Paganelli

SommarioLa terapia radiorecettoriale con 177Lu-DOTATATE (Lu-PRRT) è una valida opzione di terapia mirata nei tumori neuroendocrini pancreatici G1–G2 (pNET). È una terapia efficace in oltre l’80% dei casi. Complessivamente è ben tollerata, con tossicità midollare e renale lieve e reversibile, in particolare con frazionamento della dose totale di radiofarmaco. Nella gestione dei pazienti pNET, la PET con FDG è un importante fattore prognostico legato al metabolismo glucidico tumorale.

European Journal of Nuclear Medicine and Molecular Imaging | 2013

Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours

Stefano Severi; Oriana Nanni; Lisa Bodei; Maddalena Sansovini; Annarita Ianniello; Stefania Vittoria Luisa Nicoletti; Emanuela Scarpi; Federica Matteucci; Laura Gilardi; Giovanni Paganelli

European Journal of Nuclear Medicine and Molecular Imaging | 2014

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study.

Giovanni Paganelli; Maddalena Sansovini; Alice Ambrosetti; Stefano Severi; Manuela Monti; Emanuela Scarpi; Caterina Donati; Annarita Ianniello; Federica Matteucci; Dino Amadori

European Journal of Nuclear Medicine and Molecular Imaging | 2015

Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC

Stefano Severi; Maddalena Sansovini; Annarita Ianniello; Lisa Bodei; Silvia Nicolini; Toni Ibrahim; Valentina Di Iorio; Vincenzo D’Errico; Paola Caroli; Manuela Monti; Giovanni Paganelli

European Journal of Nuclear Medicine and Molecular Imaging | 2016

Peptide receptor radionuclide therapy with 177 Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18 F-FDG PET

Annarita Ianniello; Maddalena Sansovini; Stefano Severi; Silvia Nicolini; Chiara Grana; Katrin Massri; Alberto Bongiovanni; Lorenzo Antonuzzo; Valentina Di Iorio; Anna Sarnelli; Paola Caroli; Manuela Monti; Emanuela Scarpi; Giovanni Paganelli

European Journal of Nuclear Medicine and Molecular Imaging | 2017

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Maddalena Sansovini; Stefano Severi; Annarita Ianniello; Silvia Nicolini; Lorenzo Fantini; Emilio Mezzenga; Fabio Ferroni; Emanuela Scarpi; Manuela Monti; Alberto Bongiovanni; Sara Cingarlini; Chiara Grana; Lisa Bodei; Giovanni Paganelli

European Journal of Nuclear Medicine and Molecular Imaging | 2018

Investigation of receptor radionuclide therapy with 177 Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index

Silvia Nicolini; Stefano Severi; Annarita Ianniello; Maddalena Sansovini; Alice Ambrosetti; Alberto Bongiovanni; Emanuela Scarpi; Francesca Di Mauro; Alice Rossi; Federica Matteucci; Giovanni Paganelli

The Journal of Nuclear Medicine | 2016

Personalized 177Lu-dotatate treatment of advanced P-NENs and the value of 18F-FDG PET-CT as a prognostic factor in a long term follow up: our experience.

Stefano Severi; Maddalena Sansovini; Annarita Ianniello; Silvia Nicolini; Alice Ambrosetti; Toni Ibrahim; Mirco Bartolomei; Giovanni Paganelli

L'Endocrinologo | 2016

Erratum a: Terapia radiorecettoriale dei tumori neuroendocrini pancreatici

Silvia Nicolini; Maddalena Sansovini; Stefano Severi; Manuela Monti; Annarita Ianniello; Federica Matteucci; Giovanni Paganelli

Society of Nuclear Medicine Annual Meeting Abstracts | 2014

Retreatment with low dose 177Lu-dotatate (Lu-PRRT), in patients with GEP NENs: A prospective feasibility and activity evaluation

Stefano Severi; Lisa Bodei; Maddalena Sansovini; Annarita Ianniello; Alice Ambrosetti; Alberto Bongiovanni; Manuela Monti; Vincenzo D; Caterina Donati; Giovanni Paganelli

Explore More

Collaboration

Dive into the Annarita Ianniello's collaboration.

Top Co-Authors
Avatar

Giovanni Paganelli

European Institute of Oncology

View shared research outputs
Top Co-Authors
Avatar

Maddalena Sansovini

University of Bologna

View shared research outputs
Top Co-Authors
Avatar

Silvia Nicolini

University of Bologna

View shared research outputs
Top Co-Authors
Avatar

Emanuela Scarpi

University of Cagliari

View shared research outputs
Top Co-Authors
Avatar

Lisa Bodei

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Chiara Grana

European Institute of Oncology

View shared research outputs
Top Co-Authors
Avatar

Luigi Mansi

Seconda Università degli Studi di Napoli

View shared research outputs
Top Co-Authors
Avatar

Toni Ibrahim

Saint Joseph's University

View shared research outputs
Top Co-Authors
Avatar

Alice Rossi

University of Verona

View shared research outputs
Top Co-Authors
Avatar

Dino Amadori

University of Bologna

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge